000			01840pam a2200337 a 4500
999			_c12726 _d12726
001			3542589
005			20210302130005.0
008			970514s1997 nyua b 001 0 eng d
010			_a 97015956
020			_a082479981X (hardcover : alk. paper)
040			_aDLC _cDLC _dDLC _erda
050	0	0	_aRS380 _b.D48 1997
082	0	0	_221 _a615.6 _bD
245	0	0	_aDevelopment of biopharmaceutical parenteral dosage forms / _cedited by John A. Bontempo.
264		1	_aNew York : _bMarcel Dekker, _c1997.
300			_aix, 248 pages : _billustrations ; _c24 cm.
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
440		0	_aDrugs and the pharmaceutical sciences ; _vv. 85
504			_aIncludes bibliographical references and index.
505	0		_aCover -- Half Title -- Title Page -- Copyright Page -- Preface -- Contents -- Contributors -- 1 Introduction to the Development of Biopharmaceutical Parenteral Dosage Forms -- 2 Fermentation Process Events Affecting Biopharmaceutical Quality -- 3 Development of Recovery Processes for Recombinant Proteins and Peptides -- 4 Preformulation Development of Parenteral Biopharmaceuticals -- 5 Formulation Development -- 6 The Analytical Techniques -- 7 Membrane Filtration Technology -- 8 Considerations for Elastomeric Closures for Parenteral Biopharmaceutical Drugs -- Index
650		0	_aPharmaceutical biotechnology.
650		0	_aParenteral solutions.
700	1		_aBontempo, John A., _d1930- _eauthor
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0648/97015956-d.html
906			_a7 _bcbu _corignew _d1 _eocip _f19 _gy-gencatlg
942			_2ddc _cBK